Basal forebrain and hippocampus as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment-a multicenter DTI and volumetry study

Journal of Alzheimer's Disease

Volumn 48, Issue 1, 2015, Pages 197-204

  Brueggen, Katharina ^a   Dyrba, Martin ^a,b   Barkhof, Frederik ^c   Hausner, Lucrezia ^d   Filippi, Massimo ^e   Nestor, Peter J ^a   Hauenstein, Karlheinz ^b   Klöppel, Stefan ^f   Grothe, Michel J ^a   Kasper, Elisabeth ^g   Teipel, Stefan J ^a,g  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY OF FREIBURG   (Germany)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Alzheimer's disease; Atrophy; Basal forebrain; Cholinergic; Diffusion tensor imaging; Early diagnosis; Magnetic resonance imaging; Mild Cognitive Impairment

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; DAILY LIFE ACTIVITY; DEMENTIA; DIFFUSION TENSOR IMAGING; FOLLOW UP; FOREBRAIN; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY (TOPIC); NEUROIMAGING; PILOT STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SUPPORT VECTOR MACHINE; SURVIVAL TIME; AGED; ATROPHY; BASAL FOREBRAIN; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; EUROPE; FEMALE; INTERNATIONAL COOPERATION; MALE; MENTAL HEALTH; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BASAL FOREBRAIN; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; EUROPE; FEMALE; HIPPOCAMPUS; HUMANS; INTERNATIONAL COOPERATION; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC;

EID: 84941004017     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150063     Document Type: Article

References (50)

1. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58, 397-405.
2. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Archives of Neurology 58, 1985-1992.
3. Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, Desgranges B, Baron J-C (2005) Using voxelbased morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. NeuroImage 27, 934-946.
4. Chetelat Ga, Baron J-C (2003) Early diagnosis of Alzheimer's disease: Contribution of structural neuroimaging. NeuroImage 18, 525-541.
5. Devanand DP, Bansal R, Liu J, Hao X, Pradhaban G, Peterson BS (2012) MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. NeuroImage 60, 1622-1629.
6. Hill DLG, Schwarz AJ, Isaac M, Pani L, Vamvakas S, Hemmings R, Carrillo MC, Yu P, Sun J, Beckett L, Boccardi M, Brewer J, Brumfield M, Cantillon M, Cole PE, Fox N, Frisoni GB, Jack C, Kelleher T, Luo F, Novak G, Maguire P, Meibach R, Patterson P, Bain L, Sampaio C, Raunig D, Soares H, Suhy J, Wang H, Wolz R, Stephenson D (2014) Coalition against major diseases/European medicines agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease. Alzheimer's & Dementia 10, 421-429. e423.
7. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397-1403.
8. Li S, Okonkwo O, Albert M, Wang M-C (2013) Variation in variables that predict progression from MCI to AD dementia over duration of follow-up. American Journal of Alzheimer's Disease.
9. Mielke MM, Okonkwo OC, Oishi K, Mori S, Tighe S, Miller MI, Ceritoglu C, Brown T, Albert M, Lyketsos CG (2012) Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimer's & Dementia 8, 105-113.
10. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130, 1777-1786.
11. Grothe M, Heinsen H, Teipel SJ (2012) Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer's disease. Biological Psychiatry 71, 805-813.
12. Grothe M, ZaborszkyL, Atienza M, Gil-NecigaE, Rodriguez-Romero R, Teipel SJ, Amunts K, Suarez-Gonzalez A, Cantero JL (2010) Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Cerebral Cortex 20, 1685-1695.
13. Kilimann I, Grothe M, Heinsen H, Lopez Alho EJ, Grinberg L, Amaro E Jr, Bento dos Santos GA, Da Silva RE, Mitchell AJ, Frisoni GB, BokdeALW, Fellgiebel A, Filippi M, Hampel H, Klöppel S, Teipel SJ (2014) Subregional basal forebrain atrophy in Alzheimer's disease: A multicenter study. Journal of Alzheimer's Disease, 687-700.
14. Teipel SJ (2005) Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain 128, 2626-2644.
15. Teipel SJ, MeindlT, GrinbergL, Grothe M, Cantero JL, Reiser MF,Möller H-J, Heinsen H, HampelH (2011) The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study. Human Brain Mapping 32, 1349-1362.
16. Grothe M, Heinsen H, Teipel S (2013) Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease. Neurobiology of Aging 34, 1210-1220.
17. Selnes P, Fjell AM, Gjerstad L, Bjørnerud A, Wallin A, Due-Tønnessen P, Grambaite R, Stenset V, Fladby T (2012) White matter imaging changes in subjective and mild cognitive impairment. Alzheimer's & Dementia : The Journal of the Alzheimer's Association 8, S112-S121.
18. Vickers JC, King AE,Woodhouse A, KirkcaldieMT, Staal JA, McCormack GH, Blizzard CA, Musgrove REJ, Mitew S, Liu Y, Chuckowree JA, Bibari O, Dickson TC (2009) Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system. Neurodegenerative Diseases and Mechanisms of Cell Death 80, 217-223.
19. Zhuang L, Sachdev PS, Trollor JN, Reppermund S, Kochan NA, Brodaty H, Wen W, Zhan W (2013) Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS ONE 8, e58887.
20. Teipel SJ, Walter M, Likitjaroen Y, Schönknecht P, Gruber O. (2014) Diffusion tensor imaging in Alzheimer's disease and affective disorders. European Archives of Psychiatry and Clinical Neuroscience.
21. Clerx L, Vissera PJ, Verhey F, Aalten P (2012) New MRI Markers for Alzheimer's Disease: A meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. Journal of Alzheimer's disease : JAD 29, 405-429.
22. Fellgiebel A, Wille P, Müller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P (2004) Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: A diffusion tensor imaging study. Dementia and Geriatric Cognitive Disorders 18, 101-108.
23. Palesi F, Vitali P, Chiarati P, Castellazzi G, Caverzasi E, Pichiecchio A, Colli-Tibaldi E, D'Amore F, D'Errico I, Sinforiani E, Bastianello S (2012) DTI and MR Volumetry of hippocampus-PC/PCC Circuit: In search of early microand macrostructural signs of Alzheimers's disease. Neurology Research International 2012, 1-9.
24. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC (2001) Regional diffusivity of water in mild cognitive impairment and Alzheimer's disease.
25. Müller MJ, Greverus D, Dellani PR, Weibrich C, Wille PR, Scheurich A, Stoeter P, Fellgiebel A (2005) Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. NeuroImage 28, 1033-1042.
26. Müller MJ, Greverus D,Weibrich C, Dellani PR, Scheurich A, Stoeter P, Fellgiebel A (2007) Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI. Neurobiology of Aging 28, 398-403.
27. Fellgiebel A, Dellani PR, Greverus D, Scheurich A, Stoeter P, Müller MJ (2006) Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Research: Neuroimaging 146, 283-287.
28. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR (2005) DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64, 902-904.
29. Scola E, Bozzali M, Agosta F, Magnani G, Franceschi M, Sormani MP, Cercignani M, Pagani E, Falautano M, Filippi M, Falini A (2010) A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical followup. Journal of Neurology Neurosurgery & Psychiatry 81, 798-805.
30. Fu J-L, Liu Y, Li Y-M, Chang C, Li W-B (2013) Use of diffusion tensor imaging for evaluating changes in the microstructural integrity of white matter over 3 years in patients with amnesic-type mild cognitive impairment converting to Alzheimer's disease. Journal of Neuroimaging, n/a.
31. Kerbler GM, Hamlin AS, Pannek K, Kurniawan ND, Keller MD, Rose SE, Coulson EJ (2013) Diffusion-weighted magnetic resonance imaging detection of basal forebrain cholinergic degeneration in a mouse model. NeuroImage 66, 133-141.
32. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. Journal of Psychiatric Research 12, 189-198.
33. Morris J, Mohs R, Rogers H, Fillenbaum G, HeymanA (1987) Consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacology Bulletin 24, 641-652.
34. PetersenRC (2004) Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 256, 183-194.
35. Dyrba M, Ewers M,Wegrzyn M, Kilimann I, Plant C, Oswald A, Meindl T, Pievani M, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Klöppel S, Hauenstein K, Kirste T, Teipel SJ (2013) Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data. PLoS One 8, e64925.
36. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, Luca Md, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, Stefano Nd, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23, S208-S219.
37. Gaser C, Volz H-P, Kiebel S, Riehemann S, Sauer H (1999) Detecting structural changes in whole brain based on nonlinear deformations-application to schizophrenia research. NeuroImage 10, 107-113.
38. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38, 95-113.
39. Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M (2002) Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 22, 3234-3243.
40. Aucoin J-S, Jiang P, Aznavour N, Tong X-K, Buttini M, Descarries L, Hamel E (2005) Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Neuroscience 132, 73-86.
41. Christensen DZ, Bayer TA, Wirths O (2010) Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiology of Aging 31, 1153-1163.
42. Geula C, Nagykery N, Nicholas A, Wu C-K (2008) Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 67, 309-318.
43. Lehéricy S, Hirsch EC, Cervera-Piérot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y (1993) Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. The Journal of comparative neurology 330, 15-31.
44. Mann DM, Yates PO, Marcyniuk B (1984) Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mechanisms of Ageing and Development 25, 189-204.
45. Vogels OJM, Broere CAJ, Ter Laak HJ, Ten Donkelaar HJ, Nieuwenhuys R, Schulte BPM (1990) Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiology of Aging 11, 3-13.
46. Whitehouse P, Price D, Struble R, Clark A, Coyle J, Delon M (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215, 1237-1239.
47. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW (2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23, 994-1005.
48. Janke AL, de Zubicaray G, Rose SE, Griffin M, Chalk JB, Galloway GJ (2001) 4D deformation modeling of cortical disease progression in Alzheimer's dementia. Magn Reson Med 46, 661-666.
49. Teipel SJ, Reuter S, Stieltjes B, Acosta-Cabronero J, Ernemann U, Fellgiebel A, Filippi M, Frisoni G, Hentschel F, Jessen F, Klöppel S, MeindlT, PouwelsPJW, Hauenstein K-H, Hampel H (2011) Multicenter stability of diffusion tensor imaging measures:AEuropean clinical and physical phantom study. Psychiatry research: Neuroimaging 194, 363-371.
50. Zhu T, Hu R, Qiu X, Taylor M, TsoY,Yiannoutsos C, Navia B, Mori S, Ekholm S, Schifitto G, Zhong J (2011) Quantification of accuracy and precision of multi-center DTI measurements: A diffusion phantom and human brain study. NeuroImage 56, 1398-1411.